Syndivia

Syndivia is a biotechnology company focused on the development of next-generation targeted therapies for cancer treatment. The company unites leading experts in the fields of chemistry, bioconjugation and drug development. Syndivia develops a pipeline of innovative cancer therapies through both in-house and partnered programs. With a strong portfolio of complementary bioconjugation technologies and a unique know-how in protein modification and analysis, Syndivia is one of the leading technology providers in the field of Antibody-Drug Conjugates.